Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Endothelial Derived Hyperpolarization Factor and Regulation of Cerebral and Muscle Blood Flow

NCT05176379 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.

NCT NCT05176379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05176379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Endothelial Derived Hyperpolarization Factor and Regulation of Cerebral and Muscle Blood Flow
Lead sponsor
University of Oklahoma
Phase
Phase 4
Overall status
Unknown status
Start date
February 19, 2022
Completion date
May 31, 2025
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy